BlackRock Capital Allocation Term Trust Increases Dividend to $0.29 Per Share

BlackRock Capital Allocation Term Trust (NYSE:BCAT) made an important announcement on Thursday, September 12th, regarding its monthly dividend payments. The trust declared a dividend of $0.2871 per share for its investors. Stockholders who are on record as of Tuesday, October 15th, will receive this dividend payment on Thursday, October 31st. This new dividend equates to an annualized total of $3.45, which reflects a substantial yield of 20.91%. It is worth noting that this marks a significant increase from the trust's former monthly dividend of $0.10.

Performance of BCAT Stock

On Friday, shares of BCAT traded at $16.48, witnessing a slight rise of $0.01. During mid-day trading, the total volume of shares exchanged reached 360,595, surpassing the average volume of 352,731. The stock's fifty-day simple moving average is currently $16.33, while the two-hundred-day simple moving average stands at $16.26. Over the past year, BlackRock Capital Allocation Term Trust has seen its share prices fluctuate, with a low of $13.67 and a high of $17.18.

Insider Trading Activity

In related news, Saba Capital Management, L.P., a significant shareholder, sold 14,973 shares of BlackRock Capital Allocation Term Trust on Thursday, September 19th. The shares were sold at an average price of $16.41, leading to a total transaction amounting to approximately $245,706.93. Following this sale, Saba Capital Management now holds 16,302,733 shares valued at around $267,527,848.53. This sale reflects a 0.00% change in their ownership status. In the last three months, insiders have collectively sold 384,233 shares of the company, equating to $6,325,635 in value.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust operates under the management of BlackRock, a leading global investment management corporation. The trust aims to provide stable monthly income for shareholders through its diversified portfolio.

Considerations for Investors

Before contemplating an investment in BlackRock Capital Allocation Term Trust, it is advisable to conduct comprehensive research. Analysts currently rate the stock as a "hold"; however, there are other investment options that top analysts are suggesting might outperform BCAT. Investors should examine these alternatives before making decisions.

dividend, stocks, investment